Common Stock, Shares, Outstanding of Edwards Lifesciences Corp from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Edwards Lifesciences Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • Edwards Lifesciences Corp Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 580,700,000, a 1.3% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Edwards Lifesciences Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 580,700,000 -7,900,000 -1.3% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 580,700,000 -9,100,000 -1.5% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 587,900,000 -14,400,000 -2.4% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 586,200,000 -16,200,000 -2.7% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 588,600,000 -12,500,000 -2.1% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 589,800,000 -16,700,000 -2.8% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 602,300,000 -5,600,000 -0.92% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 602,400,000 -3,600,000 -0.59% 31 Mar 2024 10-Q 29 Apr 2024 2024 Q1
Q4 2023 601,100,000 -7,200,000 -1.2% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 606,500,000 -12,900,000 -2.1% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 607,900,000 -11,900,000 -1.9% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 606,000,000 -15,400,000 -2.5% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 608,300,000 -15,800,000 -2.5% 31 Dec 2022 10-K 12 Feb 2024 2023 FY
Q3 2022 619,400,000 -4,800,000 -0.77% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 619,800,000 -3,300,000 -0.53% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 621,400,000 -400,000 -0.06% 31 Mar 2022 10-Q 28 Apr 2022 2022 Q1
Q4 2021 624,100,000 -200,000 -0.03% 31 Dec 2021 10-K 13 Feb 2023 2022 FY
Q3 2021 624,200,000 +1,300,000 +0.21% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 623,100,000 +1,700,000 +0.27% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 621,800,000 +415,300,000 +201% 31 Mar 2021 10-Q 28 Apr 2021 2021 Q1
Q4 2020 624,300,000 +415,200,000 +199% 31 Dec 2020 10-K 14 Feb 2022 2021 FY
Q3 2020 622,900,000 +414,400,000 +199% 30 Sep 2020 10-Q 26 Oct 2020 2020 Q3
Q2 2020 621,400,000 +413,500,000 +199% 30 Jun 2020 10-Q 27 Jul 2020 2020 Q2
Q1 2020 206,500,000 -1,900,000 -0.91% 31 Mar 2020 10-Q 28 Apr 2020 2020 Q1
Q4 2019 209,100,000 +1,400,000 +0.67% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 208,500,000 -600,000 -0.29% 30 Sep 2019 10-Q 25 Oct 2019 2019 Q3
Q2 2019 207,900,000 -1,300,000 -0.62% 30 Jun 2019 10-Q 26 Jul 2019 2019 Q2
Q1 2019 208,400,000 -2,300,000 -1.1% 31 Mar 2019 10-Q 26 Apr 2019 2019 Q1
Q4 2018 207,700,000 -2,000,000 -0.95% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 209,100,000 -2,500,000 -1.2% 30 Sep 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 209,200,000 -1,900,000 -0.9% 30 Jun 2018 10-Q 27 Jul 2018 2018 Q2
Q1 2018 210,700,000 +300,000 +0.14% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 209,700,000 -1,900,000 -0.9% 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q3 2017 211,600,000 -2,100,000 -0.98% 30 Sep 2017 10-Q 27 Oct 2017 2017 Q3
Q2 2017 211,100,000 -1,600,000 -0.75% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 210,400,000 -1,500,000 -0.71% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 211,600,000 -3,800,000 -1.8% 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q3 2016 213,700,000 +106,000,000 +98% 30 Sep 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 212,700,000 +105,300,000 +98% 30 Jun 2016 10-Q 29 Jul 2016 2016 Q2
Q1 2016 211,900,000 +104,400,000 +97% 31 Mar 2016 10-Q 29 Apr 2016 2016 Q1
Q4 2015 215,400,000 +107,600,000 +100% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 107,700,000 +800,000 +0.75% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 107,400,000 +1,400,000 +1.3% 30 Jun 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 107,500,000 +2,200,000 +2.1% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 107,800,000 -1,500,000 -1.4% 31 Dec 2014 10-K 19 Feb 2016 2015 FY
Q3 2014 106,900,000 -2,500,000 -2.3% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 106,000,000 -6,200,000 -5.5% 30 Jun 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 105,300,000 -8,200,000 -7.2% 31 Mar 2014 10-Q 02 May 2014 2014 Q1
Q4 2013 109,300,000 -5,000,000 -4.4% 31 Dec 2013 10-K 20 Feb 2015 2014 FY
Q3 2013 109,400,000 -6,600,000 -5.7% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 112,200,000 -3,100,000 -2.7% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 113,500,000 -500,000 -0.44% 31 Mar 2013 10-Q 06 May 2013 2013 Q1
Q4 2012 114,300,000 +200,000 +0.18% 31 Dec 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 116,000,000 +1,800,000 +1.6% 30 Sep 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 115,300,000 +400,000 +0.35% 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 114,000,000 -800,000 -0.7% 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 114,100,000 -900,000 -0.78% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q3 2011 114,200,000 +100,000 +0.09% 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 114,900,000 +1,800,000 +1.6% 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q1 2011 114,800,000 31 Mar 2011 10-Q 09 May 2011 2011 Q1
Q4 2010 115,000,000 31 Dec 2010 10-K 27 Feb 2012 2011 FY
Q3 2010 114,100,000 30 Sep 2010 10-Q 08 Nov 2010 2010 Q3
Q2 2010 113,100,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.